| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| R-Avanafil |
4-[[(3-氯-4-甲氧基苯基)甲基]氨基]-2-[(2R)-2-(羥甲基)-1-吡咯烷基]-N-(2-嘧啶基甲基)-5-嘧啶甲酰胺 |
1638497-26-3 |
詳細(xì)
|
| PF 04995274 |
PF 04995274 |
1331782-27-4 |
詳細(xì)
|
| 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
雷芬那辛 |
864750-70-9 |
詳細(xì)
|
| EFONIDIPINE |
依福地平 |
111011-76-8 |
詳細(xì)
|
| 6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide |
6-[[3-[(二甲基氨基)羰基]苯基]磺酰]-4-[(3-甲氧基苯基)氨基]-8-甲基-3-喹啉甲酰胺 |
801312-28-7 |
詳細(xì)
|
| (R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE |
(R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE |
732278-52-3 |
詳細(xì)
|
| S-Ruxolitinib (INCB018424) |
S-魯索替尼 |
941685-37-6 |
詳細(xì)
|
| Basmisanil |
巴米沙尼 |
1159600-41-5 |
詳細(xì)
|
| Radotinib |
拉多替尼 |
926037-48-1 |
詳細(xì)
|
| EFONIDIPINE |
依福地平 |
111011-63-3 |
詳細(xì)
|
| (+)-5-(4-amino-3-methylphenyl)-7-(2-thiazolyl)-8,9-dihydro-7H-1,3-dioxolo-[4,5-h][2,3]benzodiazepine |
(R)-2-甲基-4-(8-甲基-7-(1,3,4-噻二唑-2-基)-8,9-二氫-7H-[1,3]二氧戊環(huán)并[4',5':4,5]苯并[1,2-D][1,2]二氮雜-5-基)苯胺 |
923272-18-8 |
詳細(xì)
|
| RILPIVIRINE HCL |
鹽酸利匹韋林 |
700361-47-3 |
詳細(xì)
|
| AB 1010 Mesylate |
馬賽替尼 |
1048007-93-7 |
詳細(xì)
|
| RETAPAMULIN |
瑞他莫林 |
224452-66-8 |
詳細(xì)
|
| (R)-(+)-8-methyl-5-(3-methyl-4-nitrophenyl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine |
(R)-(+)-8-METHYL-5-(3-METHYL-4-NITROPHENYL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]BENZODIAZEPINE |
732277-05-3 |
詳細(xì)
|
| Cridanimod |
1446418-48-9 |
1446418-48-9 |
詳細(xì)
|
| Shield-1 |
化合物SHIELD-1 |
914805-33-7 |
詳細(xì)
|
| 5-(2-AMINO-4-OXO-3-(2-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUIZOLIN-6-YL)-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFOMIDE |
5-(2-AMINO-4-OXO-3-(2-(TRIFLUOROMETHYL)PHENYL)-3,4-DIHYDROQUINAZOLIN-6-YL)-N-(2,4-DIFLUOROPHENYL)-2-METHOXYPYRIDINE-3-SULFONAMIDE |
1384097-27-1 |
詳細(xì)
|
| "(R)-2-(4-cyclopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide " |
2(4-環(huán)丙基苯基)-N[(1R)- 1 -[5 -(2,2,2-三氟乙氧基)吡啶-2-基]乙基]乙酰胺 |
953778-63-7 |
詳細(xì)
|
| (2R)-1,1,1-Trifluoro-2-[3-[(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl]sulfonylphenyl]propan-2-ol |
HSD-016 |
946396-92-5 |
詳細(xì)
|
| (-)-MK-801 MALEATE |
(+)-MK 801 順丁烯二酸鹽 |
77086-22-7 |
詳細(xì)
|
| LY 294002 |
LY-294,002鹽酸鹽 |
934389-88-5 |
詳細(xì)
|
| Neratinib maleate |
馬來酸來那替尼 |
915942-22-2 |
詳細(xì)
|
| Benzonitrile, 4-[2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]- |
立?？颠?/td>
| 182760-06-1 |
詳細(xì)
|
| CID 9828275 |
CBRCULCCRGSSLB-UHFFFAOYSA-N |
603987-59-3 |
詳細(xì)
|
| N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide |
BEFOTERTINIB |
1835667-63-4 |
詳細(xì)
|
| Upacicalcet |
烏帕西卡塞 |
1333218-50-0 |
詳細(xì)
|
| AGI-43192 |
化合物AGI-43192 |
2377491-54-6 |
詳細(xì)
|
| Sunvozertinib |
DZD 9008 |
2370013-12-8 |
詳細(xì)
|
| SOS1-IN-11 |
SOS1 抑制劑 |
2654741-64-5 |
詳細(xì)
|
| NRX-1933 |
化合物NRX-1933 |
2763260-30-4 |
詳細(xì)
|
| 2,6-Piperidinedione, 3-[1,3-dihydro-1-oxo-5-[1-(phenylmethyl)-4-piperidinyl]-2H-isoindol-2-yl]- |
NVP-DKY709 |
2291360-73-9 |
詳細(xì)
|
| CUR61414 |
CUR 61414 |
334998-36-6 |
詳細(xì)
|
| Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, 4,9-bis[[3-(4-methyl-1-piperazinyl)propyl]amino]-2,7-bis[3-(4-morpholinyl)propyl]- |
化合物 MM41 |
1429028-96-5 |
詳細(xì)
|
| 4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-1-pyrazolyl]-1-azetidinyl]-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide |
INCB54707 |
1637677-22-5 |
詳細(xì)
|
| 5-[2-[[[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethyl-6-imidazo[1,2-a]pyridinyl]-oxomethyl]amino]ethoxy]-5-oxopentanoic acid |
Pentanedioic acid, 1-[2-[[[8-[[(2,6-dimethylphenyl)methyl]amino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]carbonyl]amino]ethyl] ester |
1228559-81-6 |
詳細(xì)
|
| KIF18A-IN-3 |
化合物 KIF18A-IN-3 |
2600577-49-7 |
詳細(xì)
|
| nitroflurbiprofen |
158836-71-6 |
158836-71-6 |
詳細(xì)
|
| AM-5308 |
化合物 AM-5308 |
2410796-89-1 |
詳細(xì)
|
| 5H-Indeno[5,6-b]furan-3-acetamide, 6,7-dihydro-N-(5-methyl-2-thiazolyl)- |
2-{5H,6H,7H-茚并[5,6-B]呋喃-3-基}-N-(5-甲基-1,3-噻唑-2-基)乙酰胺 |
790245-61-3 |
詳細(xì)
|
| BRM/BRG1 ATP Inhibitor-2 |
化合物 BRM/BRG1 ATP INHIBITOR-2 |
2368900-77-8 |
詳細(xì)
|
| 1,4-Benzoxazepin-5(2H)-one, 4-[(4-fluorophenyl)methyl]-3,4-dihydro-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)- |
化合物TNIK-IN-3 |
2754265-25-1 |
詳細(xì)
|
| 4-[3-(cyanomethyl)-3-[4-(3,5-dimethyl-1H-pyrazol-4-yl)-1-pyrazolyl]-1-azetidinyl]-2,5-difluoro-N-[(2S)-1,1,1-trifluoropropan-2-yl]benzamide;phosphoric acid |
POVORCITINIB磷酸鹽 |
1637677-33-8 |
詳細(xì)
|
| Sovilnesib |
化合物 SOVILNESIB |
2410796-79-9 |
詳細(xì)
|
| N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[2-methyl-3-(propan-2-yl)-2H-indazol-5-yl]pyrimidin-2-amine |
化合物 ECIRUCICLIB |
1868086-40-1 |
詳細(xì)
|
| KIF18A-IN-2 |
化合物KIF18A-IN-2 |
2600559-20-2 |
詳細(xì)
|
| AGI-41998 |
化合物 AGI-41998 |
2377492-26-5 |
詳細(xì)
|
| Bicyclo[1.1.1]pentane-1-carboxylic acid, 3-[1-[[[1-(2-benzofuranylmethyl)-1H-indol-7-yl]carbonyl]amino]cyclopropyl]- |
EP4抑制劑1 |
2455480-28-9 |
詳細(xì)
|
| JQAD1 |
化合物JQAD1 |
2417097-18-6 |
詳細(xì)
|
| camonsertib |
(3-內(nèi))-3-[6-[(3R)-3-甲基-4-嗎啉基]-1-(1H-吡唑-3-基)-1H-吡唑并[3,4-B]吡啶-4-基]-8-氧雜雙環(huán)[3.2.1]辛-3-醇 |
2417489-10-0 |
詳細(xì)
|
| 1-((3aR,4S,9bS)-rel-4-(6-Bromobenzo[d][1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)ethanone |
881639-98-1 |
881639-98-1 |
詳細(xì)
|
| CS-2696 |
CS-2696 |
2097416-76-5 |
詳細(xì)
|
| 2-(4-ethylpiperazin-1-yl)-N-[4-(2-morpholin-4-yl-4-oxochromen-8-yl)dibenzothiophen-1-yl]acetamide |
KU-0060648 |
881375-00-4 |
詳細(xì)
|
| 1]Benzothieno[2,3-b]pyridine-3-carboxamide, N-[4-(aminosulfonyl)phenyl]-1,2,5,6,7,8-hexahydro-4-hydroxy-2-oxo- |
化合物 M435-1279 |
1359431-16-5 |
詳細(xì)
|
| 3-ethyl-2-[hydroxy(diphenyl)methyl]-N-[(2R)-2-hydroxypropyl]-5-benzimidazolecarboxamide |
化合物VY-3-135 |
1824637-41-3 |
詳細(xì)
|
| L-685 458 |
CS-2367 |
292632-98-5 |
詳細(xì)
|
| YB-0158 |
YB-0158 |
1144043-83-3 |
詳細(xì)
|
| CP-105,696 |
CP-105,696 |
158081-99-3 |
詳細(xì)
|
| 5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-ethyl-1-piperazinyl)-1-fluoro- |
化合物JHU 37152 |
2369979-67-7 |
詳細(xì)
|
| (R)-3-(4-(2-(4-((S)-3-chloro-2-hydroxypropoxy)phenyl)propan-2-yl)phenoxy)propane-1,2-diol |
1203490-23-6 |
1203490-23-6 |
詳細(xì)
|
| INCB 3344 |
INCB 3344 |
1262238-11-8 |
詳細(xì)
|
| CRA-02478 |
PCI-24781 |
783355-60-2 |
詳細(xì)
|
| Isoquinoline, 6-[[(2R)-hexahydro-2-methyl-1,4-diazocin-1(2H)-yl]sulfonyl]- |
化合物 COTOSUDIL |
1258833-31-6 |
詳細(xì)
|
| N-(trans-4-(3-(2-Chlorophenyl)-7-((3-methyl-4-(4-methylpiperazin-1-yl)phenyl)amino)-2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidin-1(2H)-yl)cyclohexyl)propionamide |
JND3229 |
2260886-64-2 |
詳細(xì)
|
| N6-BENZYLADENOSINE |
6-芐基腺苷 |
4294-16-0 |
詳細(xì)
|
| 4-[(1E)-2-[[(4-CHLOROPHENYL)METHYL]SULFONYL]ETHENYL]-BENZOIC ACID |
RECILISIB 鈉鹽 |
334969-03-8 |
詳細(xì)
|
| SANGIVAMYCIN |
桑霉素 |
18417-89-5 |
詳細(xì)
|
| tolamolol |
妥拉洛爾 |
38103-61-6 |
詳細(xì)
|
| ML-9 HYDROCHLORIDE |
ML-9鹽酸鹽 |
105637-50-1 |
詳細(xì)
|
| Dotinurad |
多替諾德 |
1285572-51-1 |
詳細(xì)
|
| JHU 37160 |
化合物JHU 37160 |
2369979-68-8 |
詳細(xì)
|
| CBR-5884 |
CBR-5884 |
681159-27-3 |
詳細(xì)
|
| N-[2-[4-(2-fluorophenyl)phenyl]propyl]-2-propanesulfonamide |
化合物 T27951 |
211311-39-6 |
詳細(xì)
|
| WIN 54461 |
WIN 54461 |
166599-63-9 |
詳細(xì)
|
| AB-836 |
AB-836 |
2445597-31-7 |
詳細(xì)
|
| Thieno[2,3-d]pyrimidine, 5-[3-(methylsulfonyl)phenyl]-4-[(1-methyl-1H-tetrazol-5-yl)thio]- |
NCT-504 |
1222765-97-0 |
詳細(xì)
|
| MK-0159 |
化合物 MK-0159 |
2641484-61-7 |
詳細(xì)
|
| BI-4142 |
BI-4142 |
2682003-36-5 |
詳細(xì)
|
| USP8-IN-1 |
USP8 inhibitor |
2477650-96-5 |
詳細(xì)
|
| PF-00356231 hydrochloride |
PF-00356231 HYDROCHLORIDE |
820223-77-6 |
詳細(xì)
|
| Jarin-1 |
Jarin-1 |
1212704-51-2 |
詳細(xì)
|
| 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one |
AZD4831 |
1933460-19-5 |
詳細(xì)
|
| MSC-4106 |
化合物MSC-4106 |
2738542-58-8 |
詳細(xì)
|
| 1H-Pyrazolo[3,4-d]pyrimidine, 6-(4-cyclopropyl-6-methoxy-5-pyrimidinyl)-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]- |
KSQ-4279 |
2446480-97-1 |
詳細(xì)
|
| TAS1553 |
化合物TAS1553 |
2166023-31-8 |
詳細(xì)
|
| INCB13739 |
化合物 INCB13739 |
869974-19-6 |
詳細(xì)
|
| 4-Piperidinesulfonamide, 1-ethyl-N-[[(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)amino]carbonyl]- |
化合物 SELNOFLAST |
2260969-36-4 |
詳細(xì)
|
| T-690 |
化合物 GLUCOSYLCERAMIDE SYNTHASE-IN-2 |
2597958-02-4 |
詳細(xì)
|
| Ethanone, 2-(3,5-dimethyl-1H-1,2,4-triazol-1-yl)-1-[(2R)-2-methyl-4-[2-(trifluoromethyl)-4-[2-(trifluoromethyl)-5-pyrimidinyl]-5-thiazolyl]-1-piperazinyl]- |
化合物 ACT-660602 |
1646267-59-5 |
詳細(xì)
|
| Solifenacin |
索非那新 |
242478-37-1 |
詳細(xì)
|
| Unii-5H2DV04I6O |
化合物 DS-3801B |
1369412-66-7 |
詳細(xì)
|
| RLX-33 |
RLX-33 |
2784577-71-3 |
詳細(xì)
|
| ABBV-318 |
ABBV-318 |
1802848-94-7 |
詳細(xì)
|
| Benzamide, 2-bromo-N-[2-(4-ethylphenyl)-5-benzoxazolyl]-5-nitro- |
BAY-0069 |
420826-65-9 |
詳細(xì)
|
| INDEX NAME NOT YET ASSIGNED |
化合物 BAY-252 |
2639638-67-6 |
詳細(xì)
|
| (S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
阿普斯特 |
608141-41-9 |
詳細(xì)
|
| 2,3-DIHYDROXY-6-METHYL-7-(PHENYLMETHYL)-4-PROPYL-1-NAPHTHALENECARBOXYLIC ACID |
FX11 |
213971-34-7 |
詳細(xì)
|
| Progabide |
普羅加比 |
62666-20-0 |
詳細(xì)
|
| Apararenone |
945966-46-1 |
945966-46-1 |
詳細(xì)
|
| ATR inhibitor 1 |
ATR INHIBITOR 1 |
1613200-51-3 |
詳細(xì)
|